Gould Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,400	Closed	-$295K	–	146
2018 Q3	$295K	Hold	2,400	–	–	0.12%	106
2018 Q2	$236K	Buy	+2,400	New	+$236K	0.1%	113